- recruitingPHASE2
PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
This study looks at new treatments for triple negative breast cancer that hasn't fully responded to initial chemotherapy. We're testing if medicines, given briefly before surgery, can start to shrink the cancer or change it in helpful ways.
United Kingdom - recruitingNA
Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer
This study looks at how a special exercise programme helps women with breast cancer during their treatment. We want to see if it improves their quality of life and helps reduce healthcare costs, compared to just getting general advice on exercise.
France